Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1% TID for Treatment of Ocular Inflammation Associated With Cataract Surgery

NCT01310127 is registered in ClinicalTrials.gov with Toyos Clinic as lead sponsor.

NCT NCT01310127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01310127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1% TID for Treatment of Ocular Inflammation Associated With Cataract Surgery
Lead sponsor
Toyos Clinic
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2010
Completion date
May 31, 2011
Enrollment
23 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation, pseudophakia